Editorial: treating strictures in inflammatory bowel disease-authors' reply

Florian Rieder^{1

2}, Brian G Feagan^{3

4

5}, Vipul Jairath^{3

4

5}; CONSTRICT study group

Affiliations

¹ Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
² Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
³ Robarts Clinical Trials Inc., University of Western Ontario, London, ON, Canada.
⁴ Department of Medicine, University of Western Ontario, London, ON, Canada.
⁵ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.

Editorial

Florian Rieder et al. Aliment Pharmacol Ther. 2018 Dec.

. 2018 Dec;48(11-12):1313-1314.

doi: 10.1111/apt.15032.

Florian Rieder^{1

2}, Brian G Feagan^{3

4

5}, Vipul Jairath^{3

4

5}; CONSTRICT study group

¹ Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
² Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
³ Robarts Clinical Trials Inc., University of Western Ontario, London, ON, Canada.
⁴ Department of Medicine, University of Western Ontario, London, ON, Canada.
⁵ Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada.

No abstract available

Comment on

Systematic review with meta-analysis: endoscopic balloon dilatation for Crohn's disease strictures.
Morar PS, Faiz O, Warusavitarne J, Brown S, Cohen R, Hind D, Abercrombie J, Ragunath K, Sanders DS, Arnott I, Wilson G, Bloom S, Arebi N; Crohn's Stricture Study (CroSS) Group. Morar PS, et al. Aliment Pharmacol Ther. 2015 Nov;42(10):1137-48. doi: 10.1111/apt.13388. Epub 2015 Sep 11. Aliment Pharmacol Ther. 2015. PMID: 26358739
Editorial: treating strictures in inflammatory bowel disease.
Kamm MA. Kamm MA. Aliment Pharmacol Ther. 2018 Dec;48(11-12):1312-1313. doi: 10.1111/apt.14987. Aliment Pharmacol Ther. 2018. PMID: 30488631 No abstract available.

1. Kamm M Editorial: treating inflammatory bowel disease strictures. Aliment Pharmacol Ther 2018; in press. - PubMed
1. Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn’s disease. Aliment Pharmacol Ther 2018. - PMC - PubMed
1. Vasilopoulos S, Kugathasan S, Saeian K, et al. Intestinal strictures complicating initially successful infliximab treatment for luminal Crohn’s disease. Am J Gastroenterol 2000;95:2503.
1. Toy LS, Scherl EJ, Kornbluth A, et al. Complete bowel obstruction following initial response to infliximab therapy for Crohn’s disease: a series of a newly described complication. Gastroenterology 2000;118(4):A569.
1. Lichtenstein GR, Olson A, Travers S, et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn’s disease. Am J Gastroenterol 2006;101(5):1030–8. - PubMed